“A vaccine that can protect against acne has entered early-stage trials. Using mRNA technology, the vaccine targets specific strains of the C. acnes bacterium and the inflammatory pathways thought to drive it.

Acne is one of the most prevalent diseases worldwide, with about 85% of adolescents affected, and it is increasing in prevalence in adults.

If successful, acne vaccines could mark the beginning of a new class of vaccines designed not just to stop infections, but to recalibrate the complex relationships between microbes, the immune system and chronic conditions.”

From Gavi.